Active Antigen-Specific Adaptive Immune Responses Are Shared among Patients with Progressive Fibrotic Interstitial Lung Disease
<b>Rationale:</b> Enlargement of lung-associated lymph nodes (LNs) predicts worse survival in all patients with interstitial lung disease (ILD). This phenomenon occurs in both connective tissue disease-associated ILD and, surprisingly, idiopathic pulmonary fibrosis (IPF), where immune-driven pathogenesis is controversial. <b>Objectives:</b> To determine whether immune responses in the lung LNs of patients with ILD are antigen-specific and significant to pathology and etiology. <b>Methods:</b> ILD lung LNs excised at transplant (30 IPF, 7 interstitial pneumonia with autoimmune features, 4 hypersensitivity pneumonitis, 5 connective tissue disease-associated ILD, 5 other ILD) and 36 donor control lung LNs were analyzed by spectral flow cytometry. Formalin-fixed lung LNs and OCT-fixed lung samples of patients with IPF were used to determine germinal center (GC) and antigen-specific responses. Serum autoantibody responses were measured by radioligand binding assay. <b>Measurements and Main Results:</b> All patients with ILD revealed a common adaptive immune landscape of antigen responses in lung LNs characterized by the presence of GC B cells, T follicular helper cells, and activated T cells. Immunological synapses identified in the lung LNs demonstrated that antigen stimulation is ongoing in patients with ILD. Lung LN frequencies of T follicular helper and T regulatory cells correlated with circulating antibody concentrations to ABLIM1, a recently identified autoantigen expressed widely, including in aberrant basaloid cells that are uniquely found in fibrotic lungs. <b>Conclusions:</b> Antigen-induced activation and development of GC in enlarged lung LNs represents a shared immunopathologic mechanism associated with progressive pulmonary fibrosis among patients with ILD, regardless of etiology. Autoantigens overexpressed in progressive pulmonary fibrosis may be key drivers of these GC responses.
Authors
- Imre Noth (ORCID: https://orcid.org/0000-0001-9846-5030)
- Tania Estefania Velez
- Nathan Schoettler (ORCID: https://orcid.org/0000-0001-9851-6352)
- Kavitha C. Selvan (ORCID: https://orcid.org/0000-0002-0988-0222)
- Cathryn T. Lee (ORCID: https://orcid.org/0000-0002-0963-7505)
- Catherine A. Bonham (ORCID: https://orcid.org/0000-0001-9132-4083)
- Vaibhav Upadhyay (ORCID: https://orcid.org/0000-0002-7652-1043)
- Marcus R. Clark (ORCID: https://orcid.org/0000-0003-4747-0387)
- Kelly Blaine
- Paul J. Wolters (ORCID: https://orcid.org/0000-0002-3108-6164)
- Joseph L. DeRisi (ORCID: https://orcid.org/0000-0002-4611-9205)
- Maile K. Hollinger (ORCID: https://orcid.org/0000-0001-8303-6188)
- Christopher S. Law
- Ayodeji Adegunsoye (ORCID: https://orcid.org/0000-0002-7015-9610)
- Christopher Pastore (ORCID: https://orcid.org/0000-0002-1002-6138)
- Mary E. Strek (ORCID: https://orcid.org/0000-0002-7671-1023)
- Anthony K. Shum (ORCID: https://orcid.org/0000-0001-5139-4802)
- Thomas H. Barker (ORCID: https://orcid.org/0000-0002-3218-8111)
- Sara E. Vazquez (ORCID: https://orcid.org/0000-0002-0601-7001)
- Robert D. Guzy (ORCID: https://orcid.org/0000-0001-8420-6177)
- Grace C. Bingham (ORCID: https://orcid.org/0000-0002-5223-0460)
- Anne I. Sperling (ORCID: https://orcid.org/0000-0002-4265-9212)
- Mark Stuart Anderson (ORCID: https://orcid.org/0000-0002-3093-4758)
- Young me Yoon
- Donna C. Decker
Institutions
- University of Wisconsin–Madison (US)
- University of California, San Francisco (US)
- University of Illinois Chicago (US)
- University of Chicago (US)
- University of Chicago Medical Center (US)
- Chan Zuckerberg Initiative (United States) (US)
- Pulmonary and Critical Care Associates (US)
- University of Virginia (US)
- University of San Francisco (US)
Publication Details
- Journal
- American Journal of Respiratory and Critical Care Medicine
- Published
- 2025-08-15
- DOI
- https://doi.org/10.1164/rccm.202502-0419oc
- Citations
- 1
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 1.52